Amarin to Present at Two Upcoming Investor Conferences
18 February 2021 - 10:05PM
Amarin Corporation plc (NASDAQ:AMRN) today announced that John F.
Thero, Amarin's president and chief executive officer, is scheduled
to present general company updates at the following investor
conferences scheduled in February and March:
- 10th Annual SVB Leerink Global
Healthcare conference on Friday, February 26, 2021 at 9:20 a.m.
Eastern Time (ET)
- Cowen 41st Annual Health Care
conference on Monday, March 1, 2021 at 10:20 a.m. Eastern Time
(ET)
Live audio webcasts of the presentations will be
available at: http://www.amarincorp.com, and will be accessible at
the same link for 30 days.
About Amarin Amarin is a
rapidly growing, innovative pharmaceutical company leading a new
paradigm in cardiovascular disease management. From our scientific
research foundation to our focus on clinical trials, and now our
commercial expansion, we are evolving and growing. In 2009, Amarin
had fewer than twenty employees. Today, with offices in
Bridgewater, New Jersey in the United States, Dublin in Ireland,
and Zug in Switzerland, Amarin has approximately 1,000 employees
and commercial partners and suppliers around the world. We are
committed to rethinking cardiovascular risk through the advancement
of scientific understanding of the impact on society of significant
residual risk that exists beyond traditional therapies, such as
statins for cholesterol management.
Availability of Other Information About
AmarinInvestors and others should note that Amarin
communicates with its investors and the public using the company
website (www.amarincorp.com), the investor relations website
(investor.amarincorp.com), including but not limited to investor
presentations and investor FAQs, Securities and Exchange Commission
filings, press releases, public conference calls and webcasts. The
information that Amarin posts on these channels and websites could
be deemed to be material information. As a result, Amarin
encourages investors, the media, and others interested in Amarin to
review the information that is posted on these channels, including
the investor relations website, on a regular basis. This list of
channels may be updated from time to time on Amarin’s investor
relations website and may include social media channels. The
contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries:Investor RelationsAmarin Corporation plcIn
U.S.: +1 (908) 719-1315investor.relations@amarincorp.com
Solebury
Troutlstern@soleburytrout.com
Media Inquiries:CommunicationsAmarin Corporation
plcIn U.S.: +1 (908) 892-2028pr@amarincorp.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Apr 2024 to May 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From May 2023 to May 2024